Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kush Parmar currently holds 2,691,337 shares of Homology Medicines, Inc. (FIXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kush Parmar has been a net seller of FIXX stock. They have purchased $48.6M and sold $62.3M worth of shares.
Kush Parmar's most recent insider trade was on Aug 10, 2026, when they sold 92,444 shares at $7.00 per share.
Kush Parmar serves as Executive at Homology Medicines, Inc. (FIXX). They have executed 80 insider transactions totaling $111.0M over their tenure at the company.
Kush Parmar holds the position of Executive at Homology Medicines, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Kush Parmar has shown a selling trading pattern, with $48.6M in total purchases and $62.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kush Parmar was on Apr 27, 2021, when they purchased $8.6M worth of IMPL shares. This transaction involved 575,000 shares at $15.00 per share.
Kush Parmar currently owns 2,691,337 shares of Homology Medicines, Inc. (FIXX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kush Parmar's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kush Parmar has 80 Form 4 filings on record as an insider at Homology Medicines, Inc..
Set alerts for Kush Parmar and 40,000+ other insiders.